nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—head and neck cancer—peripheral nervous system neoplasm	0.303	0.55	CtDrD
Fluorouracil—skin cancer—peripheral nervous system neoplasm	0.248	0.45	CtDrD
Fluorouracil—ABCC5—Cisplatin—peripheral nervous system neoplasm	0.0401	0.135	CbGbCtD
Fluorouracil—ABCC3—Vincristine—peripheral nervous system neoplasm	0.027	0.0909	CbGbCtD
Fluorouracil—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.0261	0.0879	CbGbCtD
Fluorouracil—ABCG2—Topotecan—peripheral nervous system neoplasm	0.026	0.0875	CbGbCtD
Fluorouracil—ABCC3—Cisplatin—peripheral nervous system neoplasm	0.0252	0.0848	CbGbCtD
Fluorouracil—ABCC3—Etoposide—peripheral nervous system neoplasm	0.0247	0.0833	CbGbCtD
Fluorouracil—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.018	0.0606	CbGbCtD
Fluorouracil—ABCC3—Doxorubicin—peripheral nervous system neoplasm	0.0169	0.0568	CbGbCtD
Fluorouracil—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0129	0.0433	CbGbCtD
Fluorouracil—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0111	0.0373	CbGbCtD
Fluorouracil—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0107	0.0361	CbGbCtD
Fluorouracil—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0103	0.0348	CbGbCtD
Fluorouracil—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0102	0.0342	CbGbCtD
Fluorouracil—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.00898	0.0302	CbGbCtD
Fluorouracil—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.00857	0.0288	CbGbCtD
Fluorouracil—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.00694	0.0233	CbGbCtD
Fluorouracil—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.00542	0.0182	CbGbCtD
Fluorouracil—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00419	0.0141	CbGbCtD
Fluorouracil—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00385	0.0129	CbGbCtD
Fluorouracil—TYMS—Vitamin A—Isotretinoin—peripheral nervous system neoplasm	0.000248	0.089	CbGdCrCtD
Fluorouracil—TYMS—Vitamin A—Tretinoin—peripheral nervous system neoplasm	0.000248	0.089	CbGdCrCtD
Fluorouracil—TYMS—Vitamin A—Alitretinoin—peripheral nervous system neoplasm	0.000188	0.0674	CbGdCrCtD
Fluorouracil—TYMS—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.000174	0.0622	CbGdCrCtD
Fluorouracil—TYMS—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.000174	0.0622	CbGdCrCtD
Fluorouracil—TYMS—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000174	0.0622	CbGdCrCtD
Fluorouracil—TYMS—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000174	0.0622	CbGdCrCtD
Fluorouracil—UMPS—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	0.000163	0.0583	CbGdCrCtD
Fluorouracil—UMPS—Idarubicin—Epirubicin—peripheral nervous system neoplasm	0.000163	0.0583	CbGdCrCtD
Fluorouracil—UMPS—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	0.000163	0.0583	CbGdCrCtD
Fluorouracil—UMPS—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.0539	CbGdCrCtD
Fluorouracil—UMPS—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.0539	CbGdCrCtD
Fluorouracil—UMPS—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.0539	CbGdCrCtD
Fluorouracil—TYMS—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000132	0.0471	CbGdCrCtD
Fluorouracil—TYMS—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000132	0.0471	CbGdCrCtD
Fluorouracil—TYMS—Vinorelbine—Vincristine—peripheral nervous system neoplasm	7.8e-05	0.028	CbGdCrCtD
Fluorouracil—TYMS—Podofilox—Etoposide—peripheral nervous system neoplasm	7.8e-05	0.0279	CbGdCrCtD
Fluorouracil—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	6.06e-05	0.000507	CcSEcCtD
Fluorouracil—Anaemia—Etoposide—peripheral nervous system neoplasm	6.03e-05	0.000505	CcSEcCtD
Fluorouracil—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	6e-05	0.000503	CcSEcCtD
Fluorouracil—Dizziness—Topotecan—peripheral nervous system neoplasm	6e-05	0.000502	CcSEcCtD
Fluorouracil—Discomfort—Cisplatin—peripheral nervous system neoplasm	5.99e-05	0.000501	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	5.98e-05	0.000501	CcSEcCtD
Fluorouracil—Dizziness—Tretinoin—peripheral nervous system neoplasm	5.95e-05	0.000498	CcSEcCtD
Fluorouracil—Dizziness—Isotretinoin—peripheral nervous system neoplasm	5.95e-05	0.000498	CcSEcCtD
Fluorouracil—Insomnia—Vincristine—peripheral nervous system neoplasm	5.94e-05	0.000498	CcSEcCtD
Fluorouracil—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	5.93e-05	0.000496	CcSEcCtD
Fluorouracil—Paraesthesia—Vincristine—peripheral nervous system neoplasm	5.9e-05	0.000494	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	5.88e-05	0.000493	CcSEcCtD
Fluorouracil—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.000492	CcSEcCtD
Fluorouracil—Leukopenia—Etoposide—peripheral nervous system neoplasm	5.84e-05	0.000489	CcSEcCtD
Fluorouracil—Pain—Alitretinoin—peripheral nervous system neoplasm	5.83e-05	0.000488	CcSEcCtD
Fluorouracil—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	5.81e-05	0.000487	CcSEcCtD
Fluorouracil—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	5.81e-05	0.000487	CcSEcCtD
Fluorouracil—Oedema—Cisplatin—peripheral nervous system neoplasm	5.81e-05	0.000487	CcSEcCtD
Fluorouracil—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	5.77e-05	0.000483	CcSEcCtD
Fluorouracil—Infection—Cisplatin—peripheral nervous system neoplasm	5.77e-05	0.000483	CcSEcCtD
Fluorouracil—Vomiting—Topotecan—peripheral nervous system neoplasm	5.76e-05	0.000483	CcSEcCtD
Fluorouracil—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	5.75e-05	0.000482	CcSEcCtD
Fluorouracil—Lethargy—Doxorubicin—peripheral nervous system neoplasm	5.73e-05	0.00048	CcSEcCtD
Fluorouracil—Vomiting—Tretinoin—peripheral nervous system neoplasm	5.72e-05	0.000479	CcSEcCtD
Fluorouracil—Vomiting—Isotretinoin—peripheral nervous system neoplasm	5.72e-05	0.000479	CcSEcCtD
Fluorouracil—Rash—Topotecan—peripheral nervous system neoplasm	5.72e-05	0.000479	CcSEcCtD
Fluorouracil—Dermatitis—Topotecan—peripheral nervous system neoplasm	5.71e-05	0.000478	CcSEcCtD
Fluorouracil—Decreased appetite—Vincristine—peripheral nervous system neoplasm	5.71e-05	0.000478	CcSEcCtD
Fluorouracil—Ataxia—Epirubicin—peripheral nervous system neoplasm	5.71e-05	0.000478	CcSEcCtD
Fluorouracil—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	5.7e-05	0.000477	CcSEcCtD
Fluorouracil—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	5.69e-05	0.000476	CcSEcCtD
Fluorouracil—Headache—Topotecan—peripheral nervous system neoplasm	5.68e-05	0.000476	CcSEcCtD
Fluorouracil—Rash—Tretinoin—peripheral nervous system neoplasm	5.67e-05	0.000475	CcSEcCtD
Fluorouracil—Rash—Isotretinoin—peripheral nervous system neoplasm	5.67e-05	0.000475	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	5.67e-05	0.000475	CcSEcCtD
Fluorouracil—Tachycardia—Cisplatin—peripheral nervous system neoplasm	5.67e-05	0.000475	CcSEcCtD
Fluorouracil—Dermatitis—Tretinoin—peripheral nervous system neoplasm	5.67e-05	0.000475	CcSEcCtD
Fluorouracil—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	5.67e-05	0.000475	CcSEcCtD
Fluorouracil—Convulsion—Etoposide—peripheral nervous system neoplasm	5.65e-05	0.000473	CcSEcCtD
Fluorouracil—Vomiting—Melphalan—peripheral nervous system neoplasm	5.64e-05	0.000473	CcSEcCtD
Fluorouracil—Headache—Tretinoin—peripheral nervous system neoplasm	5.63e-05	0.000472	CcSEcCtD
Fluorouracil—Headache—Isotretinoin—peripheral nervous system neoplasm	5.63e-05	0.000472	CcSEcCtD
Fluorouracil—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	5.62e-05	0.000471	CcSEcCtD
Fluorouracil—Pain—Vincristine—peripheral nervous system neoplasm	5.62e-05	0.000471	CcSEcCtD
Fluorouracil—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	5.61e-05	0.00047	CcSEcCtD
Fluorouracil—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	5.61e-05	0.00047	CcSEcCtD
Fluorouracil—Rash—Melphalan—peripheral nervous system neoplasm	5.6e-05	0.000469	CcSEcCtD
Fluorouracil—Dermatitis—Melphalan—peripheral nervous system neoplasm	5.59e-05	0.000468	CcSEcCtD
Fluorouracil—Dry skin—Epirubicin—peripheral nervous system neoplasm	5.56e-05	0.000466	CcSEcCtD
Fluorouracil—Chest pain—Etoposide—peripheral nervous system neoplasm	5.55e-05	0.000465	CcSEcCtD
Fluorouracil—Anorexia—Cisplatin—peripheral nervous system neoplasm	5.54e-05	0.000464	CcSEcCtD
Fluorouracil—Discomfort—Etoposide—peripheral nervous system neoplasm	5.48e-05	0.000459	CcSEcCtD
Fluorouracil—Hypotension—Cisplatin—peripheral nervous system neoplasm	5.43e-05	0.000455	CcSEcCtD
Fluorouracil—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	5.43e-05	0.000455	CcSEcCtD
Fluorouracil—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	5.42e-05	0.000454	CcSEcCtD
Fluorouracil—Urticaria—Alitretinoin—peripheral nervous system neoplasm	5.41e-05	0.000454	CcSEcCtD
Fluorouracil—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	5.39e-05	0.000451	CcSEcCtD
Fluorouracil—Nausea—Topotecan—peripheral nervous system neoplasm	5.39e-05	0.000451	CcSEcCtD
Fluorouracil—TYMS—Vinblastine—Vincristine—peripheral nervous system neoplasm	5.36e-05	0.0192	CbGdCrCtD
Fluorouracil—Confusional state—Etoposide—peripheral nervous system neoplasm	5.36e-05	0.000449	CcSEcCtD
Fluorouracil—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	5.35e-05	0.000448	CcSEcCtD
Fluorouracil—Nausea—Tretinoin—peripheral nervous system neoplasm	5.34e-05	0.000448	CcSEcCtD
Fluorouracil—Nausea—Isotretinoin—peripheral nervous system neoplasm	5.34e-05	0.000448	CcSEcCtD
Fluorouracil—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	5.34e-05	0.000447	CcSEcCtD
Fluorouracil—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	5.32e-05	0.000446	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	5.29e-05	0.000443	CcSEcCtD
Fluorouracil—Infection—Etoposide—peripheral nervous system neoplasm	5.29e-05	0.000443	CcSEcCtD
Fluorouracil—Ataxia—Doxorubicin—peripheral nervous system neoplasm	5.28e-05	0.000442	CcSEcCtD
Fluorouracil—Nausea—Melphalan—peripheral nervous system neoplasm	5.27e-05	0.000442	CcSEcCtD
Fluorouracil—Dysphagia—Epirubicin—peripheral nervous system neoplasm	5.24e-05	0.000439	CcSEcCtD
Fluorouracil—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	5.21e-05	0.000437	CcSEcCtD
Fluorouracil—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	5.21e-05	0.000436	CcSEcCtD
Fluorouracil—Tachycardia—Etoposide—peripheral nervous system neoplasm	5.19e-05	0.000435	CcSEcCtD
Fluorouracil—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	5.19e-05	0.000435	CcSEcCtD
Fluorouracil—Body temperature increased—Vincristine—peripheral nervous system neoplasm	5.19e-05	0.000435	CcSEcCtD
Fluorouracil—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	5.18e-05	0.000434	CcSEcCtD
Fluorouracil—Dry skin—Doxorubicin—peripheral nervous system neoplasm	5.15e-05	0.000431	CcSEcCtD
Fluorouracil—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	5.11e-05	0.000428	CcSEcCtD
Fluorouracil—Anorexia—Etoposide—peripheral nervous system neoplasm	5.07e-05	0.000425	CcSEcCtD
Fluorouracil—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	5.05e-05	0.000423	CcSEcCtD
Fluorouracil—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	5.03e-05	0.000421	CcSEcCtD
Fluorouracil—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	5.02e-05	0.000421	CcSEcCtD
Fluorouracil—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	5.02e-05	0.000421	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	5.01e-05	0.00042	CcSEcCtD
Fluorouracil—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	4.98e-05	0.000417	CcSEcCtD
Fluorouracil—ABCG2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	4.97e-05	0.00167	CbGpPWpGaD
Fluorouracil—Hypotension—Etoposide—peripheral nervous system neoplasm	4.97e-05	0.000416	CcSEcCtD
Fluorouracil—Pain—Cisplatin—peripheral nervous system neoplasm	4.97e-05	0.000416	CcSEcCtD
Fluorouracil—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	4.95e-05	0.000415	CcSEcCtD
Fluorouracil—UPP2—Metabolism—GNAS—peripheral nervous system neoplasm	4.93e-05	0.00166	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—GNAS—peripheral nervous system neoplasm	4.93e-05	0.00166	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.92e-05	0.00166	CbGpPWpGaD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	4.89e-05	0.00164	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—GNS—peripheral nervous system neoplasm	4.88e-05	0.00164	CbGpPWpGaD
Fluorouracil—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	4.87e-05	0.000408	CcSEcCtD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.86e-05	0.00163	CbGpPWpGaD
Fluorouracil—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.000407	CcSEcCtD
Fluorouracil—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	4.84e-05	0.000405	CcSEcCtD
Fluorouracil—UPP1—Metabolism—ABCB1—peripheral nervous system neoplasm	4.83e-05	0.00163	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.83e-05	0.00163	CbGpPWpGaD
Fluorouracil—Pruritus—Alitretinoin—peripheral nervous system neoplasm	4.82e-05	0.000404	CcSEcCtD
Fluorouracil—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	4.8e-05	0.000402	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000401	CcSEcCtD
Fluorouracil—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	4.79e-05	0.000401	CcSEcCtD
Fluorouracil—Paraesthesia—Etoposide—peripheral nervous system neoplasm	4.78e-05	0.0004	CcSEcCtD
Fluorouracil—Dyspnoea—Etoposide—peripheral nervous system neoplasm	4.74e-05	0.000397	CcSEcCtD
Fluorouracil—Somnolence—Etoposide—peripheral nervous system neoplasm	4.73e-05	0.000396	CcSEcCtD
Fluorouracil—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	4.73e-05	0.000396	CcSEcCtD
Fluorouracil—Pneumonia—Epirubicin—peripheral nervous system neoplasm	4.7e-05	0.000394	CcSEcCtD
Fluorouracil—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	4.68e-05	0.000392	CcSEcCtD
Fluorouracil—Infestation—Epirubicin—peripheral nervous system neoplasm	4.68e-05	0.000392	CcSEcCtD
Fluorouracil—Vomiting—Dactinomycin—peripheral nervous system neoplasm	4.67e-05	0.000392	CcSEcCtD
Fluorouracil—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	4.66e-05	0.000391	CcSEcCtD
Fluorouracil—Rash—Dactinomycin—peripheral nervous system neoplasm	4.64e-05	0.000388	CcSEcCtD
Fluorouracil—Decreased appetite—Etoposide—peripheral nervous system neoplasm	4.63e-05	0.000387	CcSEcCtD
Fluorouracil—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	4.61e-05	0.000386	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	4.59e-05	0.000385	CcSEcCtD
Fluorouracil—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	4.59e-05	0.000385	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	4.58e-05	0.000384	CcSEcCtD
Fluorouracil—Stomatitis—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.000382	CcSEcCtD
Fluorouracil—Pain—Etoposide—peripheral nervous system neoplasm	4.55e-05	0.000381	CcSEcCtD
Fluorouracil—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	4.55e-05	0.000381	CcSEcCtD
Fluorouracil—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	4.55e-05	0.000381	CcSEcCtD
Fluorouracil—CYP2A6—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	4.52e-05	0.00152	CbGpPWpGaD
Fluorouracil—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	4.51e-05	0.000378	CcSEcCtD
Fluorouracil—Dizziness—Alitretinoin—peripheral nervous system neoplasm	4.51e-05	0.000378	CcSEcCtD
Fluorouracil—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	4.5e-05	0.00152	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.5e-05	0.00152	CbGpPWpGaD
Fluorouracil—Diarrhoea—Vincristine—peripheral nervous system neoplasm	4.49e-05	0.000376	CcSEcCtD
Fluorouracil—PPAT—Metabolism—BCHE—peripheral nervous system neoplasm	4.45e-05	0.0015	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—BCHE—peripheral nervous system neoplasm	4.45e-05	0.0015	CbGpPWpGaD
Fluorouracil—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000371	CcSEcCtD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.42e-05	0.00149	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	4.42e-05	0.00149	CbGpPWpGaD
Fluorouracil—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	4.41e-05	0.00149	CbGpPWpGaD
Fluorouracil—Epistaxis—Epirubicin—peripheral nervous system neoplasm	4.41e-05	0.000369	CcSEcCtD
Fluorouracil—Sinusitis—Epirubicin—peripheral nervous system neoplasm	4.39e-05	0.000368	CcSEcCtD
Fluorouracil—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	4.38e-05	0.000367	CcSEcCtD
Fluorouracil—TYMS—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.38e-05	0.00147	CbGpPWpGaD
Fluorouracil—Nausea—Dactinomycin—peripheral nervous system neoplasm	4.37e-05	0.000366	CcSEcCtD
Fluorouracil—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	4.36e-05	0.000366	CcSEcCtD
Fluorouracil—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	4.35e-05	0.000365	CcSEcCtD
Fluorouracil—Dizziness—Vincristine—peripheral nervous system neoplasm	4.34e-05	0.000364	CcSEcCtD
Fluorouracil—Vomiting—Alitretinoin—peripheral nervous system neoplasm	4.33e-05	0.000363	CcSEcCtD
Fluorouracil—TYMS—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	4.33e-05	0.00146	CbGpPWpGaD
Fluorouracil—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	4.33e-05	0.000362	CcSEcCtD
Fluorouracil—Infestation—Doxorubicin—peripheral nervous system neoplasm	4.33e-05	0.000362	CcSEcCtD
Fluorouracil—Rash—Alitretinoin—peripheral nervous system neoplasm	4.3e-05	0.00036	CcSEcCtD
Fluorouracil—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	4.29e-05	0.00036	CcSEcCtD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	4.29e-05	0.00144	CbGpPWpGaD
Fluorouracil—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	4.28e-05	0.000358	CcSEcCtD
Fluorouracil—Headache—Alitretinoin—peripheral nervous system neoplasm	4.27e-05	0.000358	CcSEcCtD
Fluorouracil—ABCC5—Disease—GNS—peripheral nervous system neoplasm	4.25e-05	0.00143	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.24e-05	0.00143	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.24e-05	0.00143	CbGpPWpGaD
Fluorouracil—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	4.24e-05	0.000355	CcSEcCtD
Fluorouracil—Urticaria—Etoposide—peripheral nervous system neoplasm	4.23e-05	0.000354	CcSEcCtD
Fluorouracil—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	4.22e-05	0.000353	CcSEcCtD
Fluorouracil—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000353	CcSEcCtD
Fluorouracil—Rhinitis—Epirubicin—peripheral nervous system neoplasm	4.21e-05	0.000353	CcSEcCtD
Fluorouracil—Body temperature increased—Etoposide—peripheral nervous system neoplasm	4.21e-05	0.000352	CcSEcCtD
Fluorouracil—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	4.21e-05	0.000352	CcSEcCtD
Fluorouracil—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	4.21e-05	0.000352	CcSEcCtD
Fluorouracil—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	4.2e-05	0.000352	CcSEcCtD
Fluorouracil—PPAT—Metabolism—TH—peripheral nervous system neoplasm	4.18e-05	0.00141	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—TH—peripheral nervous system neoplasm	4.18e-05	0.00141	CbGpPWpGaD
Fluorouracil—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	4.18e-05	0.00035	CcSEcCtD
Fluorouracil—Vomiting—Vincristine—peripheral nervous system neoplasm	4.18e-05	0.00035	CcSEcCtD
Fluorouracil—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	4.17e-05	0.000349	CcSEcCtD
Fluorouracil—Rash—Vincristine—peripheral nervous system neoplasm	4.14e-05	0.000347	CcSEcCtD
Fluorouracil—Dermatitis—Vincristine—peripheral nervous system neoplasm	4.14e-05	0.000347	CcSEcCtD
Fluorouracil—Headache—Vincristine—peripheral nervous system neoplasm	4.11e-05	0.000345	CcSEcCtD
Fluorouracil—CYP2A6—NRF2 pathway—HGF—peripheral nervous system neoplasm	4.1e-05	0.00138	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—GNS—peripheral nervous system neoplasm	4.09e-05	0.00137	CbGpPWpGaD
Fluorouracil—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	4.08e-05	0.000342	CcSEcCtD
Fluorouracil—TYMS—G1/S Transition—MYC—peripheral nervous system neoplasm	4.08e-05	0.00137	CbGpPWpGaD
Fluorouracil—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	4.06e-05	0.00034	CcSEcCtD
Fluorouracil—Nausea—Alitretinoin—peripheral nervous system neoplasm	4.05e-05	0.000339	CcSEcCtD
Fluorouracil—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	4.04e-05	0.000338	CcSEcCtD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	4.01e-05	0.00135	CbGpPWpGaD
Fluorouracil—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	3.97e-05	0.000333	CcSEcCtD
Fluorouracil—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	3.92e-05	0.000328	CcSEcCtD
Fluorouracil—MTHFR—Metabolism—NME1—peripheral nervous system neoplasm	3.92e-05	0.00132	CbGpPWpGaD
Fluorouracil—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	3.9e-05	0.000327	CcSEcCtD
Fluorouracil—Nausea—Vincristine—peripheral nervous system neoplasm	3.9e-05	0.000327	CcSEcCtD
Fluorouracil—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	3.89e-05	0.000326	CcSEcCtD
Fluorouracil—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	3.88e-05	0.000325	CcSEcCtD
Fluorouracil—TYMS—Cell Cycle—AURKA—peripheral nervous system neoplasm	3.87e-05	0.0013	CbGpPWpGaD
Fluorouracil—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	3.86e-05	0.000324	CcSEcCtD
Fluorouracil—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	3.86e-05	0.000323	CcSEcCtD
Fluorouracil—MTHFR—Metabolism—COX2—peripheral nervous system neoplasm	3.77e-05	0.00127	CbGpPWpGaD
Fluorouracil—Pruritus—Etoposide—peripheral nervous system neoplasm	3.76e-05	0.000315	CcSEcCtD
Fluorouracil—TYMP—Metabolism—ENO2—peripheral nervous system neoplasm	3.75e-05	0.00126	CbGpPWpGaD
Fluorouracil—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	3.75e-05	0.000314	CcSEcCtD
Fluorouracil—Alopecia—Epirubicin—peripheral nervous system neoplasm	3.71e-05	0.000311	CcSEcCtD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.71e-05	0.00125	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.7e-05	0.00125	CbGpPWpGaD
Fluorouracil—Vomiting—Cisplatin—peripheral nervous system neoplasm	3.69e-05	0.000309	CcSEcCtD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	3.68e-05	0.00124	CbGpPWpGaD
Fluorouracil—Rash—Cisplatin—peripheral nervous system neoplasm	3.66e-05	0.000307	CcSEcCtD
Fluorouracil—Dermatitis—Cisplatin—peripheral nervous system neoplasm	3.66e-05	0.000306	CcSEcCtD
Fluorouracil—Erythema—Epirubicin—peripheral nervous system neoplasm	3.65e-05	0.000306	CcSEcCtD
Fluorouracil—Diarrhoea—Etoposide—peripheral nervous system neoplasm	3.64e-05	0.000305	CcSEcCtD
Fluorouracil—ABCC3—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.63e-05	0.00122	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.56e-05	0.0012	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—GNS—peripheral nervous system neoplasm	3.56e-05	0.0012	CbGpPWpGaD
Fluorouracil—Dizziness—Etoposide—peripheral nervous system neoplasm	3.52e-05	0.000295	CcSEcCtD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.48e-05	0.00117	CbGpPWpGaD
Fluorouracil—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	3.47e-05	0.000291	CcSEcCtD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.46e-05	0.00117	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—CHEK2—peripheral nervous system neoplasm	3.46e-05	0.00117	CbGpPWpGaD
Fluorouracil—Nausea—Cisplatin—peripheral nervous system neoplasm	3.45e-05	0.000289	CcSEcCtD
Fluorouracil—Vision blurred—Epirubicin—peripheral nervous system neoplasm	3.44e-05	0.000289	CcSEcCtD
Fluorouracil—TYMS—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	3.44e-05	0.00116	CbGpPWpGaD
Fluorouracil—Alopecia—Doxorubicin—peripheral nervous system neoplasm	3.43e-05	0.000288	CcSEcCtD
Fluorouracil—DPYD—Metabolism—GNAS—peripheral nervous system neoplasm	3.41e-05	0.00115	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—GNAS—peripheral nervous system neoplasm	3.41e-05	0.00115	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PPP3R1—peripheral nervous system neoplasm	3.41e-05	0.00115	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—NME1—peripheral nervous system neoplasm	3.41e-05	0.00115	CbGpPWpGaD
Fluorouracil—Vomiting—Etoposide—peripheral nervous system neoplasm	3.38e-05	0.000283	CcSEcCtD
Fluorouracil—Erythema—Doxorubicin—peripheral nervous system neoplasm	3.38e-05	0.000283	CcSEcCtD
Fluorouracil—Anaemia—Epirubicin—peripheral nervous system neoplasm	3.38e-05	0.000283	CcSEcCtD
Fluorouracil—CYP2A6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.36e-05	0.00113	CbGpPWpGaD
Fluorouracil—Rash—Etoposide—peripheral nervous system neoplasm	3.35e-05	0.000281	CcSEcCtD
Fluorouracil—Dermatitis—Etoposide—peripheral nervous system neoplasm	3.35e-05	0.000281	CcSEcCtD
Fluorouracil—DPYD—Metabolism—ABCB1—peripheral nervous system neoplasm	3.35e-05	0.00113	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—ABCB1—peripheral nervous system neoplasm	3.35e-05	0.00113	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	3.34e-05	0.00112	CbGpPWpGaD
Fluorouracil—Headache—Etoposide—peripheral nervous system neoplasm	3.33e-05	0.000279	CcSEcCtD
Fluorouracil—ABCC5—Metabolism—COX2—peripheral nervous system neoplasm	3.28e-05	0.0011	CbGpPWpGaD
Fluorouracil—Leukopenia—Epirubicin—peripheral nervous system neoplasm	3.27e-05	0.000274	CcSEcCtD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.19e-05	0.00107	CbGpPWpGaD
Fluorouracil—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	3.19e-05	0.000267	CcSEcCtD
Fluorouracil—TYMP—Metabolism—BCHE—peripheral nervous system neoplasm	3.17e-05	0.00107	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—GNS—peripheral nervous system neoplasm	3.17e-05	0.00107	CbGpPWpGaD
Fluorouracil—Convulsion—Epirubicin—peripheral nervous system neoplasm	3.17e-05	0.000265	CcSEcCtD
Fluorouracil—Nausea—Etoposide—peripheral nervous system neoplasm	3.16e-05	0.000265	CcSEcCtD
Fluorouracil—Anaemia—Doxorubicin—peripheral nervous system neoplasm	3.13e-05	0.000262	CcSEcCtD
Fluorouracil—Myalgia—Epirubicin—peripheral nervous system neoplasm	3.11e-05	0.000261	CcSEcCtD
Fluorouracil—Chest pain—Epirubicin—peripheral nervous system neoplasm	3.11e-05	0.000261	CcSEcCtD
Fluorouracil—Discomfort—Epirubicin—peripheral nervous system neoplasm	3.07e-05	0.000257	CcSEcCtD
Fluorouracil—TYMS—Metabolism—NME1—peripheral nervous system neoplasm	3.04e-05	0.00102	CbGpPWpGaD
Fluorouracil—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	3.03e-05	0.000254	CcSEcCtD
Fluorouracil—TYMP—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.02e-05	0.00102	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.01e-05	0.00101	CbGpPWpGaD
Fluorouracil—Confusional state—Epirubicin—peripheral nervous system neoplasm	3.01e-05	0.000252	CcSEcCtD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.98e-05	0.001	CbGpPWpGaD
Fluorouracil—Oedema—Epirubicin—peripheral nervous system neoplasm	2.98e-05	0.00025	CcSEcCtD
Fluorouracil—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	2.98e-05	0.00025	CcSEcCtD
Fluorouracil—TYMP—Metabolism—TH—peripheral nervous system neoplasm	2.98e-05	0.001	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PPP3R1—peripheral nervous system neoplasm	2.97e-05	0.000999	CbGpPWpGaD
Fluorouracil—Infection—Epirubicin—peripheral nervous system neoplasm	2.96e-05	0.000248	CcSEcCtD
Fluorouracil—MTHFR—Disease—ENO2—peripheral nervous system neoplasm	2.96e-05	0.000995	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—IFNB1—peripheral nervous system neoplasm	2.95e-05	0.000992	CbGpPWpGaD
Fluorouracil—Convulsion—Doxorubicin—peripheral nervous system neoplasm	2.93e-05	0.000245	CcSEcCtD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.93e-05	0.000985	CbGpPWpGaD
Fluorouracil—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	2.92e-05	0.000245	CcSEcCtD
Fluorouracil—TYMS—Metabolism—COX2—peripheral nervous system neoplasm	2.92e-05	0.000984	CbGpPWpGaD
Fluorouracil—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	2.92e-05	0.000245	CcSEcCtD
Fluorouracil—Tachycardia—Epirubicin—peripheral nervous system neoplasm	2.91e-05	0.000244	CcSEcCtD
Fluorouracil—Chest pain—Doxorubicin—peripheral nervous system neoplasm	2.88e-05	0.000241	CcSEcCtD
Fluorouracil—Myalgia—Doxorubicin—peripheral nervous system neoplasm	2.88e-05	0.000241	CcSEcCtD
Fluorouracil—Discomfort—Doxorubicin—peripheral nervous system neoplasm	2.84e-05	0.000238	CcSEcCtD
Fluorouracil—Anorexia—Epirubicin—peripheral nervous system neoplasm	2.84e-05	0.000238	CcSEcCtD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.84e-05	0.000954	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	2.81e-05	0.000945	CbGpPWpGaD
Fluorouracil—Hypotension—Epirubicin—peripheral nervous system neoplasm	2.79e-05	0.000233	CcSEcCtD
Fluorouracil—Confusional state—Doxorubicin—peripheral nervous system neoplasm	2.78e-05	0.000233	CcSEcCtD
Fluorouracil—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	2.76e-05	0.000231	CcSEcCtD
Fluorouracil—Oedema—Doxorubicin—peripheral nervous system neoplasm	2.76e-05	0.000231	CcSEcCtD
Fluorouracil—Infection—Doxorubicin—peripheral nervous system neoplasm	2.74e-05	0.00023	CcSEcCtD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.73e-05	0.00092	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—KNG1—peripheral nervous system neoplasm	2.73e-05	0.000919	CbGpPWpGaD
Fluorouracil—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	2.72e-05	0.000228	CcSEcCtD
Fluorouracil—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	2.71e-05	0.000227	CcSEcCtD
Fluorouracil—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	2.7e-05	0.000226	CcSEcCtD
Fluorouracil—Insomnia—Epirubicin—peripheral nervous system neoplasm	2.7e-05	0.000226	CcSEcCtD
Fluorouracil—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	2.69e-05	0.000226	CcSEcCtD
Fluorouracil—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	2.68e-05	0.000224	CcSEcCtD
Fluorouracil—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	2.66e-05	0.000223	CcSEcCtD
Fluorouracil—Somnolence—Epirubicin—peripheral nervous system neoplasm	2.65e-05	0.000222	CcSEcCtD
Fluorouracil—Anorexia—Doxorubicin—peripheral nervous system neoplasm	2.63e-05	0.00022	CcSEcCtD
Fluorouracil—ABCC4—Ectoderm Differentiation—MYC—peripheral nervous system neoplasm	2.63e-05	0.000885	CbGpPWpGaD
Fluorouracil—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	2.63e-05	0.00022	CcSEcCtD
Fluorouracil—ABCC3—Metabolism—GNS—peripheral nervous system neoplasm	2.62e-05	0.000882	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	2.61e-05	0.000877	CbGpPWpGaD
Fluorouracil—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	2.59e-05	0.000217	CcSEcCtD
Fluorouracil—Hypotension—Doxorubicin—peripheral nervous system neoplasm	2.58e-05	0.000216	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	2.57e-05	0.000216	CcSEcCtD
Fluorouracil—ABCC5—Disease—ENO2—peripheral nervous system neoplasm	2.57e-05	0.000866	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.57e-05	0.000865	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.57e-05	0.000864	CbGpPWpGaD
Fluorouracil—Pain—Epirubicin—peripheral nervous system neoplasm	2.55e-05	0.000214	CcSEcCtD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.52e-05	0.000847	CbGpPWpGaD
Fluorouracil—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	2.51e-05	0.000211	CcSEcCtD
Fluorouracil—ABCC3—Metabolism—NME1—peripheral nervous system neoplasm	2.51e-05	0.000846	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—BIRC5—peripheral nervous system neoplasm	2.51e-05	0.000845	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.5e-05	0.000841	CbGpPWpGaD
Fluorouracil—Insomnia—Doxorubicin—peripheral nervous system neoplasm	2.5e-05	0.000209	CcSEcCtD
Fluorouracil—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	2.48e-05	0.000208	CcSEcCtD
Fluorouracil—MTHFR—Metabolism—ENO2—peripheral nervous system neoplasm	2.48e-05	0.000833	CbGpPWpGaD
Fluorouracil—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	2.46e-05	0.000206	CcSEcCtD
Fluorouracil—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	2.46e-05	0.000206	CcSEcCtD
Fluorouracil—Somnolence—Doxorubicin—peripheral nervous system neoplasm	2.45e-05	0.000206	CcSEcCtD
Fluorouracil—TYMP—Metabolism—GNAS—peripheral nervous system neoplasm	2.43e-05	0.000819	CbGpPWpGaD
Fluorouracil—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	2.43e-05	0.000203	CcSEcCtD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.42e-05	0.000815	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—COX2—peripheral nervous system neoplasm	2.42e-05	0.000814	CbGpPWpGaD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.41e-05	0.000812	CbGpPWpGaD
Fluorouracil—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	2.4e-05	0.000201	CcSEcCtD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	2.4e-05	0.000807	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—GNAS—peripheral nervous system neoplasm	2.39e-05	0.000804	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—ABCB1—peripheral nervous system neoplasm	2.39e-05	0.000803	CbGpPWpGaD
Fluorouracil—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	2.38e-05	0.0002	CcSEcCtD
Fluorouracil—MTHFR—Disease—SLC2A1—peripheral nervous system neoplasm	2.38e-05	0.000802	CbGpPWpGaD
Fluorouracil—Urticaria—Epirubicin—peripheral nervous system neoplasm	2.37e-05	0.000198	CcSEcCtD
Fluorouracil—Pain—Doxorubicin—peripheral nervous system neoplasm	2.36e-05	0.000198	CcSEcCtD
Fluorouracil—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.36e-05	0.000198	CcSEcCtD
Fluorouracil—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.3e-05	0.000773	CbGpPWpGaD
Fluorouracil—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	2.29e-05	0.00077	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.28e-05	0.000769	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—HGF—peripheral nervous system neoplasm	2.28e-05	0.000766	CbGpPWpGaD
Fluorouracil—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	2.27e-05	0.00019	CcSEcCtD
Fluorouracil—CYP2A6—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.27e-05	0.000764	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.2e-05	0.00074	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.2e-05	0.00074	CbGpPWpGaD
Fluorouracil—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.2e-05	0.000184	CcSEcCtD
Fluorouracil—Urticaria—Doxorubicin—peripheral nervous system neoplasm	2.19e-05	0.000184	CcSEcCtD
Fluorouracil—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.18e-05	0.000183	CcSEcCtD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.16e-05	0.000726	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—ENO2—peripheral nervous system neoplasm	2.15e-05	0.000725	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	2.15e-05	0.000724	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	2.14e-05	0.00072	CbGpPWpGaD
Fluorouracil—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.11e-05	0.000177	CcSEcCtD
Fluorouracil—MTHFR—Metabolism—BCHE—peripheral nervous system neoplasm	2.09e-05	0.000704	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—SLC2A1—peripheral nervous system neoplasm	2.07e-05	0.000698	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.07e-05	0.000696	CbGpPWpGaD
Fluorouracil—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	2.06e-05	0.000693	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	2.05e-05	0.000691	CbGpPWpGaD
Fluorouracil—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.04e-05	0.000171	CcSEcCtD
Fluorouracil—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.03e-05	0.00017	CcSEcCtD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.03e-05	0.000683	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	2e-05	0.000674	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	2e-05	0.000672	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—SLC2A1—peripheral nervous system neoplasm	2e-05	0.000671	CbGpPWpGaD
Fluorouracil—Dizziness—Epirubicin—peripheral nervous system neoplasm	1.97e-05	0.000165	CcSEcCtD
Fluorouracil—MTHFR—Metabolism—TH—peripheral nervous system neoplasm	1.97e-05	0.000662	CbGpPWpGaD
Fluorouracil—Pruritus—Doxorubicin—peripheral nervous system neoplasm	1.95e-05	0.000164	CcSEcCtD
Fluorouracil—TYMS—Metabolism—ENO2—peripheral nervous system neoplasm	1.92e-05	0.000646	CbGpPWpGaD
Fluorouracil—Vomiting—Epirubicin—peripheral nervous system neoplasm	1.9e-05	0.000159	CcSEcCtD
Fluorouracil—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	1.89e-05	0.000158	CcSEcCtD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.89e-05	0.000634	CbGpPWpGaD
Fluorouracil—Rash—Epirubicin—peripheral nervous system neoplasm	1.88e-05	0.000158	CcSEcCtD
Fluorouracil—Dermatitis—Epirubicin—peripheral nervous system neoplasm	1.88e-05	0.000157	CcSEcCtD
Fluorouracil—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.87e-05	0.000629	CbGpPWpGaD
Fluorouracil—Headache—Epirubicin—peripheral nervous system neoplasm	1.87e-05	0.000157	CcSEcCtD
Fluorouracil—TYMS—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	1.86e-05	0.000626	CbGpPWpGaD
Fluorouracil—Dizziness—Doxorubicin—peripheral nervous system neoplasm	1.82e-05	0.000153	CcSEcCtD
Fluorouracil—ABCC5—Metabolism—BCHE—peripheral nervous system neoplasm	1.82e-05	0.000613	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	1.81e-05	0.000608	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.81e-05	0.000608	CbGpPWpGaD
Fluorouracil—Nausea—Epirubicin—peripheral nervous system neoplasm	1.77e-05	0.000148	CcSEcCtD
Fluorouracil—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	1.76e-05	0.000593	CbGpPWpGaD
Fluorouracil—Vomiting—Doxorubicin—peripheral nervous system neoplasm	1.75e-05	0.000147	CcSEcCtD
Fluorouracil—Rash—Doxorubicin—peripheral nervous system neoplasm	1.74e-05	0.000146	CcSEcCtD
Fluorouracil—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	1.74e-05	0.000146	CcSEcCtD
Fluorouracil—ABCC5—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.74e-05	0.000584	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	1.73e-05	0.000583	CbGpPWpGaD
Fluorouracil—Headache—Doxorubicin—peripheral nervous system neoplasm	1.73e-05	0.000145	CcSEcCtD
Fluorouracil—ABCC5—Metabolism—TH—peripheral nervous system neoplasm	1.71e-05	0.000576	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	1.67e-05	0.000561	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	1.66e-05	0.00056	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.66e-05	0.000559	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GNS—peripheral nervous system neoplasm	1.64e-05	0.000553	CbGpPWpGaD
Fluorouracil—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.64e-05	0.000137	CcSEcCtD
Fluorouracil—TYMS—Metabolism—BCHE—peripheral nervous system neoplasm	1.62e-05	0.000546	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—GNAS—peripheral nervous system neoplasm	1.61e-05	0.00054	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.6e-05	0.000538	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ENO2—peripheral nervous system neoplasm	1.59e-05	0.000535	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—ABCB1—peripheral nervous system neoplasm	1.58e-05	0.00053	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—NME1—peripheral nervous system neoplasm	1.57e-05	0.00053	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	1.57e-05	0.00053	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.55e-05	0.000522	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.55e-05	0.000521	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.54e-05	0.000519	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—TH—peripheral nervous system neoplasm	1.52e-05	0.000513	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.52e-05	0.00051	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—COX2—peripheral nervous system neoplasm	1.52e-05	0.00051	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.49e-05	0.000501	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—AKT1—peripheral nervous system neoplasm	1.43e-05	0.000481	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—GNAS—peripheral nervous system neoplasm	1.4e-05	0.00047	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—ABCB1—peripheral nervous system neoplasm	1.37e-05	0.000461	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—BCHE—peripheral nervous system neoplasm	1.34e-05	0.000452	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	1.33e-05	0.000449	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PTPN11—peripheral nervous system neoplasm	1.33e-05	0.000448	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—AKT1—peripheral nervous system neoplasm	1.33e-05	0.000447	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—AKT1—peripheral nervous system neoplasm	1.33e-05	0.000447	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.29e-05	0.000434	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.28e-05	0.000431	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.28e-05	0.000431	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.26e-05	0.000425	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—TH—peripheral nervous system neoplasm	1.26e-05	0.000425	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	1.26e-05	0.000424	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.25e-05	0.000421	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—GNAS—peripheral nervous system neoplasm	1.24e-05	0.000419	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	1.24e-05	0.000416	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—ABCB1—peripheral nervous system neoplasm	1.22e-05	0.000411	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.16e-05	0.000391	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PTPN11—peripheral nervous system neoplasm	1.16e-05	0.00039	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—MYC—peripheral nervous system neoplasm	1.13e-05	0.000379	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	1.12e-05	0.000378	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GNS—peripheral nervous system neoplasm	1.12e-05	0.000375	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	1.1e-05	0.000369	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	1.08e-05	0.000364	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.08e-05	0.000363	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.08e-05	0.000362	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NME1—peripheral nervous system neoplasm	1.07e-05	0.00036	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—ERBB2—peripheral nervous system neoplasm	1.05e-05	0.000354	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.05e-05	0.000353	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.04e-05	0.000348	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—GNAS—peripheral nervous system neoplasm	1.03e-05	0.000347	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	1.03e-05	0.000347	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—COX2—peripheral nervous system neoplasm	1.03e-05	0.000346	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.01e-05	0.00034	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—NRAS—peripheral nervous system neoplasm	9.98e-06	0.000336	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ENO2—peripheral nervous system neoplasm	9.95e-06	0.000335	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.36e-06	0.000315	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—TP53—peripheral nervous system neoplasm	9.26e-06	0.000312	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	9.25e-06	0.000311	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—AKT1—peripheral nervous system neoplasm	9.22e-06	0.00031	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—AKT1—peripheral nervous system neoplasm	9.22e-06	0.00031	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	9.18e-06	0.000309	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—ERBB2—peripheral nervous system neoplasm	9.16e-06	0.000308	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	9.13e-06	0.000307	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	8.97e-06	0.000302	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.83e-06	0.000297	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	8.75e-06	0.000295	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	8.7e-06	0.000293	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	8.43e-06	0.000284	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—BCHE—peripheral nervous system neoplasm	8.41e-06	0.000283	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.02e-06	0.00027	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—NRAS—peripheral nervous system neoplasm	8.01e-06	0.00027	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—TH—peripheral nervous system neoplasm	7.91e-06	0.000266	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	7.8e-06	0.000263	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TP53—peripheral nervous system neoplasm	7.64e-06	0.000257	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	7.51e-06	0.000253	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	7.48e-06	0.000252	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MYC—peripheral nervous system neoplasm	7.46e-06	0.000251	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—HRAS—peripheral nervous system neoplasm	7.3e-06	0.000246	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	7.2e-06	0.000242	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	7.1e-06	0.000239	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—NRAS—peripheral nervous system neoplasm	6.97e-06	0.000235	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	6.97e-06	0.000235	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	6.8e-06	0.000229	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	6.76e-06	0.000227	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—AKT1—peripheral nervous system neoplasm	6.57e-06	0.000221	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MYC—peripheral nervous system neoplasm	6.49e-06	0.000219	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GNAS—peripheral nervous system neoplasm	6.45e-06	0.000217	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—AKT1—peripheral nervous system neoplasm	6.45e-06	0.000217	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ABCB1—peripheral nervous system neoplasm	6.33e-06	0.000213	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—HRAS—peripheral nervous system neoplasm	5.86e-06	0.000197	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	5.74e-06	0.000193	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	5.71e-06	0.000192	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	5.66e-06	0.00019	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	5.53e-06	0.000186	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.48e-06	0.000184	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.45e-06	0.000183	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	5.4e-06	0.000182	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—TH—peripheral nervous system neoplasm	5.37e-06	0.000181	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—AKT1—peripheral nervous system neoplasm	5.17e-06	0.000174	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—HRAS—peripheral nervous system neoplasm	5.1e-06	0.000172	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	4.73e-06	0.000159	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	4.67e-06	0.000157	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	4.52e-06	0.000152	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—AKT1—peripheral nervous system neoplasm	4.5e-06	0.000152	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.46e-06	0.00015	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	4.41e-06	0.000148	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	4.39e-06	0.000148	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	4.38e-06	0.000147	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—AKT1—peripheral nervous system neoplasm	4.33e-06	0.000146	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	4.33e-06	0.000146	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	4.3e-06	0.000145	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	3.99e-06	0.000134	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.81e-06	0.000128	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—AKT1—peripheral nervous system neoplasm	3.77e-06	0.000127	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	3.76e-06	0.000126	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	3.59e-06	0.000121	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	3.52e-06	0.000118	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	3.46e-06	0.000116	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—AKT1—peripheral nervous system neoplasm	3.36e-06	0.000113	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	3.3e-06	0.000111	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	3.07e-06	0.000103	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	3.01e-06	0.000101	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	2.92e-06	9.82e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AKT1—peripheral nervous system neoplasm	2.78e-06	9.36e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	1.92e-06	6.45e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AKT1—peripheral nervous system neoplasm	1.74e-06	5.86e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	1.19e-06	4e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	1.18e-06	3.98e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	9.68e-07	3.26e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	8.28e-07	2.78e-05	CbGpPWpGaD
